查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869603

專業化PACS（個人影像通訊系統）市場規模、佔有率和趨勢分析報告：按專業化、部署模式、最終用途、地區和細分市場預測（2025-2033年）

Specialty Picture Archiving And Communication System Market Size, Share & Trends Analysis Report By Specialty, By Deployment Mode, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

專業PACS（影像存檔和通訊系統）市場摘要

2024年全球專業PACS（影像存檔和通訊系統）市場規模估計為37.4億美元，預計2033年將達到65.7億美元。

預計從 2025 年到 2033 年，該行業將以 6.6% 的複合年成長率成長。這一成長歸功於數位成像解決方案的日益普及、醫學影像檢查數量的增加、對遠端放射學和遠距離診斷的需求不斷成長、政府對醫療保健 IT 普及的舉措和監管支持，以及雲端基礎的PACS 解決方案的技術進步。

此外，人工智慧 (AI) 與專業影像歸檔和通訊系統 (PACS) 的日益融合是塑造市場的另一個新興趨勢。醫學影像檢查數量的不斷成長是專業 PACS 產業發展的關鍵促進因素。這一成長是由慢性病患病率上升、人口老化以及診斷成像技術的進步所推動的，這些進步拓展了診斷能力。隨著心臟病學、乳房X光檢查、整形外科和牙科等專科的掃描量不斷增加，醫療機構在儲存、搜尋和管理大量複雜影像資料方面面臨日益嚴峻的挑戰。根據《美國放射學會雜誌》報導，診斷成像的使用率預計將從2023年的16.9%成長到2055年的26.9%，凸顯了對高效影像管理系統日益成長的需求。這進一步強調了對專業 PACS（影像存檔和通訊系統）解決方案的必要性，這些解決方案提供客製化的工作流程、高級視覺化功能和高效的資料管理，以便更快地進行解讀、增強協作並改善患者預後。

遠距放射學的日益普及正在推動專業PACS（影像歸檔和通訊系統）市場的成長。醫療機構越來越依賴遠距離診斷服務來應對放射科醫生短缺的問題，擴大專業技術的取得管道，並實現觀察報告。 Merative預測，2033年，美國可能面臨高達42,000名放射科醫師的缺口。遠距放射學能夠即時實現多地點共用醫學影像，包括CT、MRI、乳房X光攝影超音波，從而加快診斷速度並確保醫療服務的連續性，尤其是在農村和醫療資源匱乏的地區。專業PACS（影像歸檔和通訊系統）解決方案透過提供基於雲端基礎的存取、安全的影像共用和特定專業的流程來滿足這一需求，從而實現放射科醫生和轉診醫生之間跨地域的無縫協作。這有助於提高效率、縮短報告時間並提升診斷準確性。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業機會分析
    • 產業問題分析
    • 技術概述
    • 企業級安全與合規性概述
    • 案例研究
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章 專業PACS（影像歸檔與通訊系統）市場：專業評估與趨勢分析

  • 專業細分儀表板
  • 專業市佔率變化分析，2024 年及 2033 年
  • 按專業領域分類的市場規模、預測與趨勢分析，2021-2033年
  • 放射科 PACS
  • 心臟病學PACS
  • 乳房X光攝影PACS
  • 整形外科PACS
  • 眼科PACS
  • 病理PACS
  • 腫瘤/放射治療PACS
  • 其他

第5章 專業PACS市場：部署模式估算及趨勢分析

  • 已部署模式儀表板
  • 按部署模式分類的市場佔有率變化分析（2024 年和 2033 年）
  • 按部署模式分類的市場規模、預測與趨勢分析，2021-2033年
  • 雲端基礎/基於網路
  • 本地部署
  • 混合

6. 專業PACS市場：終端用戶估算與趨勢分析

  • 最終用戶細分儀表板
  • 2024 年及 2033 年最終用戶市佔率變化分析
  • 按最終用途分類的市場規模、預測和趨勢分析，2021-2033年
  • 醫院
  • 專科診所
  • 診斷影像中心
  • 遠端醫療和遠距放射學服務提供者
  • 其他

第7章 專業PACS（個人影像控制系統）市場：區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場：主要結論
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與者概覽
  • 企業市場分析/企業市佔率分析（2024 年）
  • 公司分類
  • 策略規劃
  • 公司簡介
    • Novarad
    • INFINITT North America Inc.
    • Sectra AB
    • Intelerad
    • Koninklijke Philips NV
    • GE HealthCare
    • FUJIFILM Corporation
    • Canon Medical Systems, USA.
    • Agfa HealthCare
    • Merative
    • Ramsoft
    • Optum, Inc.
    • Siemens Healthineers AG
    • Medstrat
    • Candelis Corporation
    • Phoenix Ortho
Product Code: GVR-4-68040-762-9

Specialty PACS Market Summary

The global specialty picture archiving and communication system market size was estimated at USD 3.74 billion in 2024 and is projected to reach USD 6.57 billion by 2033, growing at a CAGR of 6.6% from 2025 to 2033. This growth is attributed to rising adoption of digital imaging solutions, the increasing volume of medical imaging procedures, growing demand for tele radiology and remote diagnostics, Government initiatives and regulatory support for healthcare IT adoption, and Technological advancements in cloud-based PACS solutions.

Moreover, the growing integration of artificial intelligence (AI) into specialty PACS is an emerging trend shaping the market. The increasing volume of medical imaging procedures is a major driver for the specialty (Picture Archiving And Communication System) PACS industry. The growth is fueled by the rising prevalence of chronic diseases, an aging population, and advances in imaging modalities that expand diagnostic capabilities. As more scans are performed across specialties such as cardiology, mammography, orthopedics, and dentistry, healthcare providers face growing challenges in storing, retrieving, and managing large volumes of complex image data. According to the Journal of the American College of Radiology, imaging utilization is projected to rise from 16.9% in 2023 to 26.9% by 2055, highlighting the accelerating demand for efficient imaging management systems which further emphasizes the need for specialty PACS solutions that offer tailored workflows, advanced visualization, and streamlined data management to enable faster interpretation, improved collaboration, and better patient outcomes.

Rising adoption of tele radiology is driving growth in the specialty PACS market, as healthcare providers increasingly rely on remote diagnostic services to address radiologist shortages, expand access to expertise, and enable around-the-clock reporting. According to Merative, by 2033, the U.S. could face a shortage of up to 42,000 radiologists. Tele radiology allows medical images from modalities such as CT, MRI, mammography, and ultrasound to be shared instantly across locations, supporting faster diagnoses and continuity of care, particularly in rural or underserved regions. Specialty PACS solutions complement this demand by offering cloud-based access, secure image sharing, and specialty-specific workflows that ensure seamless collaboration between radiologists and referring physicians across geographies, improving efficiency, turnaround times, and diagnostic accuracy.

Global Specialty PACS Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global specialty PACS market report based on specialty, deployment mode, end use, and region:

  • Specialty Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiology PACS
  • Cardiology PACS
  • Mammography PACS
  • Orthopedic PACS
  • Ophthalmology PACS
  • Pathology PACS
  • Oncology / Radiation Therapy PACS
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-Based/ Web-Based
  • On-premise
  • Hybrid
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Telemedicine & Tele radiology Providers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Specialty
    • 1.2.2. Deployment Mode
    • 1.2.3. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising adoption of digital imaging solutions
      • 3.2.1.2. Increasing volume of medical imaging procedures
      • 3.2.1.3. Expanding remote access and telemedicine adoption
      • 3.2.1.4. Growing demand for specialty-specific imaging
      • 3.2.1.5. Increasing integration with EHR/EMR and RIS systems
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High implementation and maintenance costs
      • 3.2.2.2. Data privacy and security concerns
      • 3.2.2.3. Limited availability of skilled workforce to operate and manage PACS
      • 3.2.2.4. Complex and varying regulatory requirements across regions
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Technology Overview
      • 3.2.5.1. AI & Machine Learning
      • 3.2.5.2. 3D Visualization & Reconstruction
      • 3.2.5.3. Automated Workflow & Reporting Tools
      • 3.2.5.4. Cloud Storage & Remote Access
    • 3.2.6. Company-Level Security & Compliance Overview
    • 3.2.7. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Specialty PACS Market: Specialty Estimates & Trend Analysis

  • 4.1. Specialty Segment Dashboard
  • 4.2. Specialty Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Specialty, 2021 to 2033 (USD Million)
  • 4.4. Radiology PACS
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cardiology PACS
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Mammography PACS
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Orthopedic PACS
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Ophthalmology PACS
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Pathology PACS
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Oncology / Radiation Therapy PACS
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Others
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Specialty PACS Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Deployment Mode Dashboard
  • 5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
  • 5.4. Cloud-Based/ Web-Based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-Premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Hybrid
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Specialty PACS Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. End Use Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Diagnostic Imaging Centers
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Telemedicine & Tele radiology Providers
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Specialty PACS Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Specialty PACS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis/Company Market Share Analysis (2024)
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Novarad
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. INFINITT North America Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Sectra AB
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Intelerad
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Koninklijke Philips N.V.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. GE HealthCare
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. FUJIFILM Corporation
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Canon Medical Systems, USA.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Agfa HealthCare
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Merative
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Ramsoft
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Optum, Inc.
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Siemens Healthineers AG
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Medstrat
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Candelis Corporation
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Phoenix Ortho
      • 8.5.16.1. Overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of secondary data sources
  • Table 3 North America Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 5 North America Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 6 North America Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 7 US Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 8 US Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 9 US Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 11 Canada Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 12 Canada Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 14 Mexico Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 15 Mexico Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 18 Europe Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 19 Europe Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Germany Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 21 Germany Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 22 Germany Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 24 UK Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 25 UK Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 26 France Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 27 France Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 28 France Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Italy Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 30 Italy Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 31 Italy Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Spain Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 33 Spain Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 34 Spain Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Sweden Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 36 Sweden Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 37 Sweden Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 39 Denmark Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 40 Denmark Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Norway Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 42 Norway Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 43 Norway Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 48 China Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 49 China Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 50 China Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 51 Japan Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 52 Japan Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 53 Japan Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 54 India Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 55 India Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 56 India Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Australia Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 58 Australia Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 59 Australia Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Thailand Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 61 Thailand Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 62 Thailand Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 64 South Korea Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 65 South Korea Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Latin America Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 68 Latin America Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 69 Latin America Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Brazil Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 71 Brazil Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 72 Brazil Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Argentina Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 74 Argentina Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 75 Argentina Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 76 MEA Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 77 MEA Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 78 MEA Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 79 MEA Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 80 South Africa Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 81 South Africa Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 82 South Africa Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 86 UAE Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 87 UAE Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 88 UAE Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Specialty PACS market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Specialty PACS market: Market outlook
  • Fig. 5 Specialty PACS market: Segment outlook
  • Fig. 6 Specialty PACS market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Specialty PACS market Driver Impact
  • Fig. 9 Specialty PACS market Restraint impact
  • Fig. 10 Specialty PACS market, specialty outlook: Key takeaways, (USD Million)
  • Fig. 11 Specialty PACS market: specialty movement analysis (USD Million)
  • Fig. 12 Radiology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Cardiology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Mammography PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Orthopedic PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Ophthalmology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Pathology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Oncology / Radiation Therapy PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Specialty PACS market, deployment mode outlook key takeaways (USD Million)
  • Fig. 21 Specialty PACS market: deployment mode movement analysis (USD Million)
  • Fig. 22 Cloud-Based/Web-Based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 On-Premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Hybrid market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Specialty PACS market, end use outlook key takeaways (USD Million)
  • Fig. 26 Specialty PACS market: end use movement analysis (USD Million)
  • Fig. 27 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Specialty Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Diagnostic Imaging Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Telemedicine & Teleradiology Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Specialty PACS market: Regional outlook, 2024 & 2033
  • Fig. 34 North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 US Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)